Literature DB >> 9933128

Availability of Lyme disease vaccine.

.   

Abstract

On December 21, 1998, the Food and Drug Administration (FDA) licensed LYMErix (SmithKline Beecham Biologicals, Reixensart, Belgium), a new vaccine against Lyme disease (LD). This report summarizes information about this vaccine and provides epidemiologic information about LD relevant to vaccine use.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9933128

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN： 0149-2195            Impact factor:   17.586


  4 in total

1.  Strain typing of Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii by using multiple-locus variable-number tandem repeat analysis.

Authors:  Jason Farlow; Danielle Postic; Kimothy L Smith; Zack Jay; Guy Baranton; Paul Keim
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 2.  Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications.

Authors:  G Wang; A P van Dam; I Schwartz; J Dankert
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

3.  Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model.

Authors:  Chiung-Yi Huang; Jeremy J W Chen; Kuan-Yin Shen; Li-Sheng Chang; Yi-Chen Yeh; I-Hua Chen; Pele Chong; Shih-Jen Liu; Chih-Hsiang Leng
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

Review 4.  Surveillance of arthropod vector-borne infectious diseases using remote sensing techniques: a review.

Authors:  Satya Kalluri; Peter Gilruth; David Rogers; Martha Szczur
Journal:  PLoS Pathog       Date:  2007-10-26       Impact factor: 6.823
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.